The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Help the ACR Bring Its Message to the Hill

Help the ACR Bring Its Message to the Hill

September 6, 2017 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR will be back on Capitol Hill Sept. 26 to advocate for lower out-of-pocket costs of prescription drugs and the repeal of arbitrary Medicare therapy caps, as well as to shed light on the role of pharmacy benefit managers (PBMs) in drug pricing. But it will take the voice of all rheumatology professionals and patients to get Congress to act.

You Might Also Like
  • Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill
  • Rheumatology Champions Call for Lower Prescription Drug Costs, and More in Meeting with Congressional Legislators
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
Also By This Author
  • Hardship Exception Applications Open for Clinicians Struggling with Quality Payment Program Reporting in 2020

How can you help us strengthen the ACR’s message in D.C.? Write, call or email your legislators using the ACR’s Legislative Action Center. As a constituent, your members of Congress are elected to represent you. Ask them to support the following priorities:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Reduce Patients’ Out-of-Pocket Expenses

  • Ask your representative in the House to co-sponsor H.R. 2999, the Patients’ Access to Treatments Act (PATA), which would limit patients’ cost-sharing requirements for specialty-tier drugs and increase access to life-saving biologics.
  • Ask your senator to introduce PATA in the Senate. You can also sign a member letter requesting a Senate hearing.

Repeal Medicare Therapy Caps

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Ask your representative in the House to support H.R. 807, the Medicare Access to Rehabilitation Services Act, which would repeal the cap on outpatient rehabilitation services.
  • Ask your senator to co-sponsor S.253, the Medicare Access to Rehabilitation Services Act.

In addition, you can help expose the role of PBMs in prescription drug pricing to your representatives and senators:

  • PBMs can drive up drug costs by creating market pressure for higher list prices (the higher the list price, the higher the rebate).
  • PBMs use their position to negotiate contracts with manufacturers, insurers and pharmacies that maximize their profits, often at the expense of patients.
  • PBMs use spread pricing, in which they charge an insurer a different amount for given drugs than what they reimburse the pharmacy for dispensing the drugs. This may be kept as extra profit by the PBM.
  • PBMs use drug-switching practices, which increase profits by steering patients toward expensive medications whose manufacturers pay rebates to PBMs for promoting a particular drug.

Other Ways to Get Involved
How can you be an effective advocate when members of Congress are at home?

  • Invite your legislators to your office. This is a great opportunity to educate members of Congress on the importance of the rheumatology subspecialty and the effect that arthritis and rheumatic conditions have on quality of life.
  • Meet with your legislators in their district office. An in-person meeting is an effective way to convey your message and allows you to build relationships with your legislators.
  • Volunteer for a campaign. Volunteering is a great way to get involved in the political process. Support the candidate who will best represent the rheumatology community.

We must stay united if we want to effect change, so contact your elected officials and make your voice heard. To find your legislators’ contact information or for more information on ACR advocacy activities, contact [email protected], or visit www.rheumatology.org/advocacy.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College, Legislation & Advocacy Tagged With: ACR Capitol Hill visit, Advocates for Arthritis 2017, lower out-of-pocket costs of prescription drugs, Medicare therapy caps, pharmacy benefit managers (PBMs)

You Might Also Like:
  • Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill
  • Rheumatology Champions Call for Lower Prescription Drug Costs, and More in Meeting with Congressional Legislators
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
  • Participate in Virtual Capitol Hill Meetings with the ACR

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)